David Protein Says ‘Diet’ Trends Are Over, GLP-1s Upend Markets
David Rahal, founder and CEO of David Protein, argues GLP-1 drugs have upended the diet-trend cycle, reshaping how br...
Explore when to make changes to your spending plan and how to rebalance categories so you stay aligned with goals and cash flow.
23,566 articlesDavid Rahal, founder and CEO of David Protein, argues GLP-1 drugs have upended the diet-trend cycle, reshaping how br...
A bold $60 billion move redefines SpaceX's path into AI-enabled tools and developer software. This article explains w...
Ethereum hovers around $1,585 after a sharp weekly slide, with analyst Tom Lee arguing that quarter-end window dressi...
As traders chase SpaceX pre-IPO chatter, Planet Labs stands out with a high-margin, subscription-backed data model an...
A rising governance proposal centers on a 5% government stake in OpenAI, aiming to align AI safety with policy goals ...
A free cash flow ETF is delivering a surprising edge in 2026, outperforming the S&P 500 as investors rotate toward ca...
Greg Abel is moving Berkshire Hathaway beyond its familiar bets. After a bold $23 billion purchase in a single stock,...
South Korea has started enforcing a new law that penalties for spreading false information. Journalists warn it could...
Strive disclosed a marked drop in fair value for Strategy’s STRC, signaling a bitcoin treasury’s paper loss that coul...
A CEO of a roughly $5 billion software company says he goes beyond listed references, seeking unlisted sources to ass...
As AI agents become more embedded in crypto tools, researchers warn that hallucinations could trick these agents into...
Mega-cap tech now drives most S&P 500 gains, leaving the rest of the market with thinner support. Here’s what investo...